Proposed mechanisms linking T2DM with prostate cancer diagnosis and outcomes include alterations in androgen receptor availability, lowered testosterone levels, and insulin resistance in men with T2DM (14–16). The gene discussed is AR; the disease is type 2 diabetes mellitus.